123 related articles for article (PubMed ID: 1840228)
1. Pharmacological properties and functions of central 5-HT3 receptors.
Costall B; Naylor RJ
Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
Costall B; Naylor RJ
Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
[TBL] [Abstract][Full Text] [Related]
3. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
Tyers MB
Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
[TBL] [Abstract][Full Text] [Related]
4. [Ondansetron--the first highly selective 5-HT3 antagonist in therapy of psychiatric diseases].
Broocks A
Fortschr Neurol Psychiatr; 1992 Jun; 60(6):227-36. PubMed ID: 1386589
[TBL] [Abstract][Full Text] [Related]
5. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
[TBL] [Abstract][Full Text] [Related]
6. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
[TBL] [Abstract][Full Text] [Related]
7. Serotonin receptor and reuptake sites: pharmacologic significance.
Gonzalez-Heydrich J; Peroutka SJ
J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
[TBL] [Abstract][Full Text] [Related]
8. The neuronal 5-HT3 receptor network after 20 years of research--evolving concepts in management of pain and inflammation.
Faerber L; Drechsler S; Ladenburger S; Gschaidmeier H; Fischer W
Eur J Pharmacol; 2007 Mar; 560(1):1-8. PubMed ID: 17316606
[TBL] [Abstract][Full Text] [Related]
9. 5-HT3 receptors in selective animal models of cognition.
Sridhar N; Veeranjaneyulu A; Arulmozhi DK; Gupta CN; Babu RJ
Indian J Exp Biol; 2002 Feb; 40(2):174-80. PubMed ID: 12622180
[TBL] [Abstract][Full Text] [Related]
10. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
[TBL] [Abstract][Full Text] [Related]
11. Central 5-HT3 receptor stimulation by m-CPBG increases blood glucose in rats.
Carvalho F; Macêdo D; Bandeira I; Maldonado I; Salles L; Azevedo MF; Rocha MA; Fregoneze JB; De Castro-e-Silva E
Horm Metab Res; 2002 Feb; 34(2):55-61. PubMed ID: 11972287
[TBL] [Abstract][Full Text] [Related]
12. Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.
Costall B; Naylor RJ
Pharmacol Toxicol; 1992 Dec; 71(6):401-15. PubMed ID: 1362267
[TBL] [Abstract][Full Text] [Related]
13. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats.
Ito C; Isobe Y; Kawamura R; Kiuchi Y; Tsuchida K; Higuchi S
J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183
[TBL] [Abstract][Full Text] [Related]
14. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.
Shankar RP; Karan RS; Handu SS; Bhargava VK
Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627
[TBL] [Abstract][Full Text] [Related]
15. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
[TBL] [Abstract][Full Text] [Related]
16. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
Moulignier A
Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.
Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J
Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and anti-emetic properties of ondansetron.
Tyers MB; Bunce KT; Humphrey PP
Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S15-9. PubMed ID: 2533894
[TBL] [Abstract][Full Text] [Related]
19. Role of 5-HT3 and 5-HT2C receptors located within the medial amygdala in the control of salt intake in sodium-depleted rats.
Luz C; Souza A; Reis R; Fregoneze JB; de Castro e Silva E
Brain Res; 2006 Jul; 1099(1):121-32. PubMed ID: 16765332
[TBL] [Abstract][Full Text] [Related]
20. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
